Thor Halfdanarson, Professor of Oncology at Mayo Clinic School of Medicine, shared on X:
“Are you like I, struggling with sequencing systemic therapies in G2/G3 GEPNETs and wondering where PRRT fits in that picture…? If so, you might find this paper helpful. Sure, we need better data but here is what we know.”
Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared a post by Thor Halfdanarson, adding:
“Always a privilege to collaborate with my two fantastic and highly experienced colleagues. How do we sequence treatments in NETs? There’s method to the madness.”
Title: Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT
Authors: Aman Chauhan,Thorvardur R. Halfdanarson, Namrata Vijayvergia
Read the Full Article.
